OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Lithocholic Acid, a Metabolite of the Microbiome, Increases Oxidative Stress in Breast Cancer
Patrik Kovács, Tamás Csonka, Tündé Kovàcs, et al.
Cancers (2019) Vol. 11, Iss. 9, pp. 1255-1255
Open Access | Times Cited: 95

Showing 26-50 of 95 citing articles:

Targeted Inhibition of Anti-Inflammatory Regulator Nrf2 Results in Breast Cancer Retardation In Vitro and In Vivo
Venugopal R. Bovilla, Mahadevaswamy G. Kuruburu, Vidya G. Bettada, et al.
Biomedicines (2021) Vol. 9, Iss. 9, pp. 1119-1119
Open Access | Times Cited: 34

Natural compounds targeting nuclear receptors for effective cancer therapy
Mangala Hegde, Sosmitha Girisa, Nikunj Naliyadhara, et al.
Cancer and Metastasis Reviews (2022) Vol. 42, Iss. 3, pp. 765-822
Closed Access | Times Cited: 23

Mechanism of ferroptosis in breast cancer and research progress of natural compounds regulating ferroptosis
Anqi Ge, Qi He, Zhao Da, et al.
Journal of Cellular and Molecular Medicine (2023) Vol. 28, Iss. 1
Open Access | Times Cited: 13

The involvement of oncobiosis and bacterial metabolite signaling in metastasis formation in breast cancer
Tündé Kovàcs, Edit Mikó, Gyula Ujlaki, et al.
Cancer and Metastasis Reviews (2021) Vol. 40, Iss. 4, pp. 1223-1249
Open Access | Times Cited: 31

Inhibition of the NRF2/KEAP1 Axis: A Promising Therapeutic Strategy to Alter Redox Balance of Cancer Cells
Emiliano Panieri, Luciano Saso
Antioxidants and Redox Signaling (2021) Vol. 34, Iss. 18, pp. 1428-1483
Closed Access | Times Cited: 30

Bile acids as regulatory molecules and potential targets in metabolic diseases
Ai-jin Xie, Chu-Tian Mai, Yi Zhun Zhu, et al.
Life Sciences (2021) Vol. 287, pp. 120152-120152
Closed Access | Times Cited: 28

Lithocholic acid inhibits gallbladder cancer proliferation through interfering glutaminase-mediated glutamine metabolism
Weijian Li, Zeyu Wang, Ruirong Lin, et al.
Biochemical Pharmacology (2022) Vol. 205, pp. 115253-115253
Closed Access | Times Cited: 22

Elevated bile acid metabolism and microbiome are associated with suppressed cell proliferation and better survival in breast cancer.
Rongrong Wu, Irene Yu, Yoshihisa Tokumaru, et al.
PubMed (2022) Vol. 12, Iss. 11, pp. 5271-5285
Closed Access | Times Cited: 22

The pro- and antineoplastic effects of deoxycholic acid in pancreatic adenocarcinoma cell models
Szandra Schwarcz, Patrik Kovács, Tündé Kovàcs, et al.
Molecular Biology Reports (2023) Vol. 50, Iss. 6, pp. 5273-5282
Open Access | Times Cited: 12

The Interplay between Microbiota and Chemotherapy-Derived Metabolites in Breast Cancer
Julio Plaza‐Díaz, Ana I. Álvarez‐Mercado
Metabolites (2023) Vol. 13, Iss. 6, pp. 703-703
Open Access | Times Cited: 11

Research status of indole-modified natural products
Song-Fang Duan, Lei Song, Hongyan Guo, et al.
RSC Medicinal Chemistry (2023) Vol. 14, Iss. 12, pp. 2535-2563
Closed Access | Times Cited: 11

Endoscopic surgery affects the gut microbiota and its metabolism in breast cancer patients
Jingtai Li, Fangfang Gao, Runwei Li, et al.
Frontiers in Microbiology (2025) Vol. 15
Open Access

Decoding TGR5: A Comprehensive Review of Its Impact on Cerebral Diseases
Zehan Zhang, Yifei Zhang, Hongye Peng, et al.
Pharmacological Research (2025), pp. 107671-107671
Open Access

Research Progress of Gut Microbiota in Immunity and Breast Cancer
俊丽 任
Advances in Clinical Medicine (2025) Vol. 15, Iss. 03, pp. 184-191
Closed Access

Insights into the gut microbiome-metabolite dynamics in breast cancer
Haseeb Manzoor, Masood ur Rehman Kayani
Gut Microbes Reports (2025) Vol. 2, Iss. 1, pp. 1-23
Open Access

The cancer microbiome
Huapeng Li, Anne A. Leaman, Qingfei Zheng
Advances in clinical chemistry (2025)
Closed Access

Targeting Nuclear NAD+ Synthesis Inhibits DNA Repair, Impairs Metabolic Adaptation and Increases Chemosensitivity of U-2OS Osteosarcoma Cells
Alexandra Kiss, Arnold Péter Ráduly, Zsolt Regdon, et al.
Cancers (2020) Vol. 12, Iss. 5, pp. 1180-1180
Open Access | Times Cited: 30

Comparison of the Gut Microbiota in Patients with Benign and Malignant Breast Tumors: A Pilot Study
Peidong Yang, Zhitang Wang, Qingqin Peng, et al.
Evolutionary Bioinformatics (2021) Vol. 17
Open Access | Times Cited: 27

The Bile Acid Membrane Receptor TGR5 in Cancer: Friend or Foe?
Youchao Qi, Guozhen Duan, Deng-Bang Wei, et al.
Molecules (2022) Vol. 27, Iss. 16, pp. 5292-5292
Open Access | Times Cited: 18

Scroll to top